Tyra Biosciences Q2 EPS $(0.31) Beats $(0.34) Estimate
Portfolio Pulse from Benzinga Newsdesk
Tyra Biosciences reported Q2 losses of $(0.31) per share, beating the analyst consensus estimate of $(0.34) by 8.82 percent. This represents a 13.89 percent improvement over losses of $(0.36) per share from the same period last year.
August 10, 2023 | 9:16 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Tyra Biosciences' Q2 losses were less than expected, indicating a potential improvement in the company's financial performance.
Tyra Biosciences reported lower than expected losses for Q2, which is a positive sign for the company's financial health. This could lead to increased investor confidence and potentially a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100